About Company
Sotac Pharmaceuticals of the Sotac Group manufactures pharmaceutical products for clients on a loan license and contract manufacturing basis. As of date, they have 162 corporate clients.
The company was incorporated in 2015 and set up a manufacturing unit in Ahmedabad, Gujarat, in 2017. The manufacturing unit has an annual installed capacity of ₹90 crore tables and ₹14 crore capsules.
The company has two primary lines of business:
- Pharmaceutical products – Non-beta Lactam capsules, tablets, and syrups.
- Therapeutic portfolio – Anti-diabetic, Antipsychotic, Vitamins, Minerals, Iron, Anti-cold, Anti-allergic, Derma products, Antacids, etc.
Cadila Pharma, J.B. Chemical, Lincoln Pharma, Viatris (Mylan), Makers (IPCA), Corona remedies, Eris Life Science, etc. are a few prominent clients of Sotac pharmaceuticals.
The bidding window of Sotac Pharmaceuticals IPO worth ₹33.30 Cr will open on March 29, 2023, and close on April 03, 2023. The IPO contains 3,000,000 equity shares with a face value of ₹10. The price band for the book-building IPO is fixed at ₹105-111 per share.
| Bidding Dates 29 Mar ’23 – 03 Apr ’23 | Price Range ₹105-111 |
| Minimum Investment ₹133,200 / 1 Lots (1200 Shares ) | Maximum Investment ₹133,200 / 1 Lots (1200 Shares ) |
| Investor category and sub category Qualified Institutional Buyers | Non-Institutional Investors | Retail Individual Investors | Issue Size ₹33.30 Cr |
Sotac Pharmaceuticals IPO Dates
Important dates with respect to IPO allotment and listing
| IPO Opening Date Mar 29, 2023 | IPO Closing Date Apr 3, 2023 |
| Basis of Allotment Apr 10, 2023 | Initiation of Refunds Apr 11, 2023 |
| Credit of Shares to Demat Account Apr 12, 2023 | IPO Listing Date Apr 13, 2023 |
IPO Subscription Details
| Date | QIB | NII | Retail | Total |
|---|---|---|---|---|
| Day 1 Mar 29, 2023 | 0.00 | 0.00 | 0.05 | 0.02 |
| Day 2 Mar 31, 2023 | 0.00 | 0.72 | 0.15 | 0.23 |
| Day 3 Apr 3, 2023 | 1.00 | 4.04 | 0.91 | 1.60 |
IPO Subscription Status Live
| Investor Category | Subscription (Times) |
|---|---|
| Qualified Institutions Buyers | 1.00 |
| Non-Institutional Buyers | 4.04 |
| Retail Investors | 0.91 |
| Employees | [.] |
| Others | [.] |
| Total | 1.60 |
Sotac Pharmaceuticals Ltd. IPO Objective
- Investing in subsidiary and construction/upgradation of new/existing buildings in the current premises
- Meeting capital expenditure requirements and general corporate purposes
- Meet issue expenses
Should you invest in Sotac Pharmaceuticals Ltd.?
These are the top reasons to consider investing in Sotac Pharmaceutical Ltd.
- The company serves various companies for formulation development, clinical batch production, and commercial-scale production.
- The brand has a presence in 14 Indian states and has started direct export to distributors in the international market under the vertical of direct selling.
- It markets 34 products manufactured under its brand name in the offshore market and 14 in the USA market.
Sotac Pharmaceuticals Ltd. Noteworthy highlights
- It has permission to produce 329 products under one license and 45 under a Food and Drug Department license.
- It was featured among the ‘Top 10 Pharma Contract Manufacturers in India’ by Indian Pharma Outlook in 2022.
Sotac Pharmaceuticals Company Financials
| Particulars | 6 months ending in September 30,2022 | Year ending on March 31, 2022 (₹ lakh) | Year ending on March 31, 2021 |
|---|---|---|---|
| Revenue from Operations | 3,974.83 | 7,314.17 | 4,884.32 |
| Profit After Tax (PAT) (consolidated) | 46.55 | 287.86 | 236.54 |
| PAT Margin | 9.98% | 4.61% | 1,97% |
| EBITDA | 534.44 | 613.52 | 280.12 |
| EBITDA % | 17.32% | 8.36% | 6.44% |
| Period Ended | As on March 31, 2022 | As on March 31, 2021 | As on March 31, 2020 |
| Current Asset | 2,727.32 | 1,332.70 | 1,307.15 |
| Current Liability | 2,118.78 | 1,094.97 | 1,051.75 |
Know before investing
Strengths
- The company manufactures and markets products under its brand name, which includes tablets, capsules, and syrups in the domestic and international markets.
- The promoters have a combined experience of 59 years.
- It operates in a scalable business model.
Risks
- The promoter group and group of Companies are involved in certain litigations and claims.
- It relies on a few customers to generate revenue.
- It is dependent on external suppliers for raw materials.
Please Click Here To Apply For Sotac Pharmaceuticals Ltd. IPO
#ipo #stockmarket #bitcoin #money #trading #forextrader #investment #wallstreet #stocks #entrepreneur #forex #trader #investor #investing #cryptocurrency #invest #business #daytrader #binaryoptions #forexsignals #profit #success #finance #wealth #makemoneyonline #forexlifestyle #forextrading #motivation #millionaire #entrepreneurship #daytrading #thrillingsecurities #thrilling